🇨🇿 Czech Republic Country × Condition
hereditary diseases Clinical Trials in Czech Republic
Active clinical trials for hereditary diseases with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇿 Czech Republic
Active Trials in Czech Republic (2)
NCT06549725
Recruiting
Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening
Enrollment
419 pts
Country
🇨🇿 Czech Republic
Lipidica, a.s.
View Trial → NCT06330441
Recruiting
Pancreatic Cancer Screening in a Population at High Risk
Enrollment
700 pts
Country
🇨🇿 Czech Republic
Masaryk Memorial Cancer Institute
View Trial → Frequently Asked Questions
How many hereditary diseases clinical trials are active in Czech Republic?
There are currently 2 active clinical trials for hereditary diseases with sites in Czech Republic, of which 2 are actively recruiting patients.
How can I join a hereditary diseases clinical trial in Czech Republic?
To join a hereditary diseases clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hereditary diseases trials in Czech Republic?
Active hereditary diseases trials in Czech Republic span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology